Safety of pull-type and introducer percutaneous endoscopic gastrostomy tubes in oncology patients: a retrospective analysis

Evi Van Dyck, Elisabeth J Macken, Bernard Roth, Paul A Pelckmans, Tom G Moreels, Evi Van Dyck, Elisabeth J Macken, Bernard Roth, Paul A Pelckmans, Tom G Moreels

Abstract

Background: Percutaneous endoscopic gastrostomy (PEG) allows long-term tube feeding. Safety of pull-type and introducer PEG placement in oncology patients with head/neck or oesophageal malignancies is unknown.

Methods: Retrospective analysis of 299 patients undergoing PEG tube placement between January 2006 and December 2008 revealed 57 oncology patients. All patients with head/neck or oesophageal malignancy were treated with chemo- and radiotherapy. In case of high-grade stenosis introducer Freka® Pexact PEG tube was placed (n = 24) and in all other patients (n = 33) conventional pull-type PEG tube. Short-term complications and mortality rates were compared.

Results: Patients' characteristics and clinical status were comparable in both groups. Short-term complications were encountered in 11/24 (48%) introducer PEG patients as compared to only 4/33 (12%) pull-type PEG patients (P < 0.05). Accidental removal of the introducer PEG tube occurred in 4/24 (17%) with need for surgical intervention in 1 vs. 0/33 (0%, P < 0.05). Wound infection occurred in 3/24 (12%) leading to septic shock and admission to intensive care unit (ICU) in 1 vs. 3/33 (9%, NS). Finally, 3/24 gastrointestinal perforations (12%) resulted from a difficult placement procedure vs. 1/33 (3%), leading to urgent surgical intervention and admission to ICU. Two introducer PEG patients died at ICU, resulting in an overall mortality rate of 8% vs. 0% (P = 0.091).

Conclusion: The introducer Freka® Pexact PEG procedure for long-term tube feeding may lead to significantly higher complication and mortality rates in patients with head/neck or oesophageal malignancies treated with chemo- and radiotherapy. It is suggested to use the conventional pull-type PEG tube placement in this group of patients, if possible.

Figures

Figure 1
Figure 1
Freka® Pexact procedure showing the double needle to create a 2-suture gastropexy.
Figure 2
Figure 2
Freka® Pexact procedure showing introduction of the trocar with the peal-away sheet and final position of the temporary PEG tube.

References

    1. Gauderer MW, Ponsky JL, Izant RJ Jr. Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg. 1980;15:872–875. doi: 10.1016/S0022-3468(80)80296-X.
    1. Gauderer M. Twenty years of percutaneous endoscopic gastrostomy: origin and evolution of a concept and its expanded applications. Gastrointest Endosc. 1999;50:879–883. doi: 10.1016/S0016-5107(99)70186-0.
    1. Nicholson FB, Korman MG, Richardson MA. Percutaneous endoscopic gastrostomy, a review of indications, complications and outcome. J Gastroenterol Hepatol. 2000;15:21–5. doi: 10.1046/j.1440-1746.2000.02004.x.
    1. Jafri NS, Mahid SS, Minor KS, Idstein SR, Hornung CA, Galandiuk S. Meta-analysis: antibiotic prophylaxis to prevent peristomal infection following percutaneous endoscopic gastrostomy. Aliment Pharmacol Ther. 2007;25:647–656. doi: 10.1111/j.1365-2036.2007.03247.x.
    1. Adelson RT, Ducic Y. Metastatic head and neck carcinoma to a percutaneous endoscopic gastrostomy site. Head Neck. 2005;27:339–343. doi: 10.1002/hed.20159.
    1. Wejda BU, Deppe H, Huchzermeyer H, Dormann AJ. PEG placement in patients with ascites: a new approach. Gastrointest Endosc. 2005;61:178–180. doi: 10.1016/S0016-5107(04)02449-6.
    1. Baltz JG, Argo CK, Al-Osaimi AM, Northup PG. Mortality after percutaneous endoscopic gastrostomy in patients with cirrhosis: a case series. Gastrointest Endosc. 2010. in press .
    1. Kadota T, Nakagawa K, Taguchi J, Ono H, Hiaide H, Tmakuma S, Ueno F. A simplified percutaneous endoscopic gastrostomy using the trocar introducer technique with peel-away sheath. Surg Gynecol Obstet. 1991;173:490–4.
    1. Dormann AJ, Glosemeyer R, Leistner U, Deppe H, Roggel R, Wigginghaus B, Huchzermeyer H. Modified percutaneous endoscopic gastrostomy (PEG) with gastropexy: Early experience with a new introducer technique. Z Gastroenterol. 2000;38:933–938. doi: 10.1055/s-2000-10025.
    1. Yuki M, Amano Y, Komazawa Y, Fukuhara H, Shizuku T, Yamamoto S, Kinoshita Y. Unsedated transnasal small-caliber esophagogastroduodenoscopy in elderly and bedridden patients. World J Gastroenterol. 2009;15:5586–5591. doi: 10.3748/wjg.15.5586.
    1. Mekhail TM, Adelstein DJ, Rybicki LA, Larto MA, Saxton JP, Lavertu P. Enteral nutrition during the treatment of head and neck carcinoma. Is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube ? Cancer. 2001;91:1785–1790. doi: 10.1002/1097-0142(20010501)91:9<1785::AID-CNCR1197>;2-1.
    1. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–655. doi: 10.1097/00000421-198212000-00014.
    1. Schulenberg E, Schüle S, Lehnert T. Emergency surgery for complications related to percutaneous endoscopic gastrostomy. Endoscopy. 2010;42:872–874. doi: 10.1055/s-0030-1255761.
    1. Vargo JJ, Ponsky JL. Percutaneous endoscopic gastrostomy: clinical applications: recognition and treatment of complications. MedGenMed. 2000;2(4)
    1. Gay F, El Nawar A, Van Gossum A. Percutaneous endoscopic gastrostomy. Acta Gatroenterol Belg. 1992;55:285–294.
    1. Larson DE, Burton DD, Schroeder KW, DiMagno EP. Percutaneous endoscopic gastrostomy. Indications, success, complications, and mortality in 314 consecutive patients. Gastroenterology. 1987;93:48–52.
    1. Grant DG, Bradley PT, Pothier DD, Bailey D, Caldera S, Baldwin DL, Birchall MA. Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-institution study, systematic review and meta-analysis. Clin Otolaryngol. 2009;34:103–112. doi: 10.1111/j.1749-4486.2009.01889.x.
    1. Dorman AJ, Wejda B, Kahl S, Huchzemeyer H, Ebert MP, Malfertheiner P. Long-term results with a new introducer method with gastropexy for percutaneous endoscopic gastrostomy. Am J Gastroenterology. 2006;101:1229–1234. doi: 10.1111/j.1572-0241.2006.00541.x.
    1. Shastri JM, Hoepffner N, Tessmer A, Ackermann H, Schroeder O, Stein J. New introducer PEG gastropexy does not require prophylactic antibiotics: multicenter prospective randomized double-blind placebo-controlled study. Gastrointest Endosc. 2008;67:620–628. doi: 10.1016/j.gie.2007.10.044.
    1. Galaski A, Peng WW, Ellis M, Darling P, Common A, Tucker E. Gastrostomy tube placement by radiological versus endoscopic methods in an acute care setting: a retrospective review of frequency, indications, complications and outcomes. Can J Gastroenterol. 2009;23:109–114.
    1. Cosentini EP, Sautner T, Gnant M, Winkelbauer F, Teleky B, Jakesz R. Outcomes of surgical, percutaneous, endoscopic, and percutaneous radiologic gastrostomies. Arch Surg. 1998;133:1076–1083. doi: 10.1001/archsurg.133.10.1076.
    1. ASGE Technology Committee. Kwon RS, Banerjee S, Desilets D, Diehl DL, Farraye FA, Kaul V, Mamula P, Pedrosa MC, Rodriguez SA, Varadarajulu S, Song LM, Tierney WM. Enteral nutrition access devices. Gastrointest Endosc. 2010;72:236–248. doi: 10.1016/j.gie.2010.02.008.
    1. Campoli PM, Cardoso DM, Turchi MD, Ejima FH, Mota OM. Assessment of safety and feasibility of a new technical variant of gastropexy for percutaneous endoscopic gastrostomy: an experience with 435 cases. BMC Gastroenterol. 2009;9:4. doi: 10.1186/1471-230X-9-48.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi